Abstract
In this paper, we address the preparation of the EPC and HEPC sterically stabilized doxorubicin liposomes and report the data collected from further studies on pharmacokinetics in blood for choosing a better carrier in delivering the drugs. The pharmacokinetics of EPC and HEPC sterically stabilized liposomes (EPC-SSL, and HEPC-SSL) in Wistar rats were investigated by HPLC. The results showed that the mean residence time of HEPC-SSL in blood is 23.3 h, while that of EPC-SSL is 12.0 h. In conclusion, HEPC-SSL is a better carrier in delivering the drugs to the extravascular sites when compared with EPC-SSL.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibiotics, Antineoplastic / administration & dosage
-
Antibiotics, Antineoplastic / pharmacokinetics
-
Delayed-Action Preparations / chemical synthesis*
-
Delayed-Action Preparations / pharmacokinetics
-
Doxorubicin / administration & dosage*
-
Doxorubicin / pharmacokinetics*
-
Drug Carriers / chemistry*
-
Hydrogenation
-
Liposomes
-
Phosphatidylcholines / chemistry
-
Phosphatidylcholines / pharmacology*
-
Rats
Substances
-
Antibiotics, Antineoplastic
-
Delayed-Action Preparations
-
Drug Carriers
-
Liposomes
-
Phosphatidylcholines
-
Doxorubicin